Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
Clinical trial NCT06420440 · RECRUITING
Trial details
- NCT number
- NCT06420440
- Sponsor
- Chen Xiaoping
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-05-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.